What does MEDISKIN do?

MEDISKIN is a specialist medical practice in Dilbeek. Private Limited, started on 6 June 2016, 1 establishment.

What is the address of MEDISKIN?

The registered office of MEDISKIN is located at Begijnenborrestraat 26, 1700 Dilbeek.

Is MEDISKIN still active?

Yes. According to the CBE (16 September 2026) MEDISKIN is active, legal situation “Normale toestand”, started on 6 June 2016.

Is MEDISKIN registered on Peppol?

Yes, MEDISKIN is registered on the Peppol network with ID 0208:0655933992.

What is the enterprise number of MEDISKIN?

The enterprise number of MEDISKIN is BE0655933992.

When was MEDISKIN founded?

MEDISKIN was founded on 6 June 2016.

Who are the directors of MEDISKIN?

According to the 2025 annual accounts, the directors of MEDISKIN are: Lauranne Pierret.

Is MEDISKIN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 June 2016; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MEDISKIN make in 2025?

MEDISKIN posted a profit after taxes of € 81,971 in financial year 2025.

What is the revenue of MEDISKIN?

As a small company, MEDISKIN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 130,871.

MEDISKIN (Private Limited) - Dilbeek - BE0655933992

Dossier MEDISKIN, printed on 16 September 2026 from databakkes.be/en/0655933992/mediskin. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MEDISKIN from Dilbeek, company number BE0655933992, closed financial year 2025 with a result of € 81,971 after tax. For that financial year MEDISKIN recorded a gross margin of € 130,871 and equity of € 210,486. Compared with financial year 2024, the result moved from € 79,374 to € 81,971. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 17, 2026.

What it is worth Healthy

€ 210,486

▼ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 81,971

▲ 3% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 207,066

▼ 16% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 81,971 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 13,748

▼ 44% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 110,325

▼ 13% vs 2024

€ 17,703 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 2,962

▼ 7% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 12,391

▲ 2% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 129,900 Gross margin 2022: € 129,900 First fiscal year in the series	€ 103,146 Gross margin 2023: € 103,146 ▼ 21% vs 2022 (€ 129,900) Unfavourable step	€ 128,084 Gross margin 2024: € 128,084 ▲ 24% vs 2023 (€ 103,146) Favourable step	€ 130,871 Gross margin 2025: € 130,871 ▲ 2% vs 2024 (€ 128,084) Favourable step	▲ 2%
Profit after taxes	€ 81,750 Profit after taxes 2022: € 81,750 First fiscal year in the series	€ 59,251 Profit after taxes 2023: € 59,251 ▼ 28% vs 2022 (€ 81,750) Unfavourable step	€ 79,374 Profit after taxes 2024: € 79,374 ▲ 34% vs 2023 (€ 59,251) Favourable step	€ 81,971 Profit after taxes 2025: € 81,971 ▲ 3% vs 2024 (€ 79,374) Favourable step	▲ 3%
Equity	€ 310,336 Equity 2022: € 310,336 First fiscal year in the series	€ 287,837 Equity 2023: € 287,837 ▼ 7% vs 2022 (€ 310,336) Unfavourable step	€ 228,586 Equity 2024: € 228,586 ▼ 21% vs 2023 (€ 287,837) Unfavourable step	€ 210,486 Equity 2025: € 210,486 ▼ 8% vs 2024 (€ 228,586) Unfavourable step	▼ 8%
Total debts	€ 173,110 Total debts 2022: € 173,110 First fiscal year in the series	€ 156,388 Total debts 2023: € 156,388 ▼ 10% vs 2022 (€ 173,110) Favourable step	€ 219,952 Total debts 2024: € 219,952 ▲ 41% vs 2023 (€ 156,388) Unfavourable step	€ 207,803 Total debts 2025: € 207,803 ▼ 6% vs 2024 (€ 219,952) Favourable step	▼ 6%
Cash	€ 274,135 Cash 2022: € 274,135 First fiscal year in the series	€ 224,231 Cash 2023: € 224,231 ▼ 18% vs 2022 (€ 274,135) Unfavourable step	€ 247,492 Cash 2024: € 247,492 ▲ 10% vs 2023 (€ 224,231) Favourable step	€ 207,066 Cash 2025: € 207,066 ▼ 16% vs 2024 (€ 247,492) Unfavourable step	▼ 16%
Land & buildings	€ 144,510 Land & buildings 2022: € 144,510 First fiscal year in the series	€ 138,108 Land & buildings 2023: € 138,108 ▼ 4% vs 2022 (€ 144,510) Unchanged	€ 136,063 Land & buildings 2024: € 136,063 ▼ 1% vs 2023 (€ 138,108) Unchanged	€ 123,050 Land & buildings 2025: € 123,050 ▼ 10% vs 2024 (€ 136,063) Unchanged	▼ 10%
Retained profit	€ 291,736 Retained profit 2022: € 291,736 First fiscal year in the series	€ 269,237 Retained profit 2023: € 269,237 ▼ 8% vs 2022 (€ 291,736) Unfavourable step	€ 209,986 Retained profit 2024: € 209,986 ▼ 22% vs 2023 (€ 269,237) Unfavourable step	€ 209,986 Retained profit 2025: € 209,986 Unchanged (€ 209,986) Unchanged
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 81,750 Dividend 2023: € 81,750 Unchanged (€ 0) Unchanged	€ 138,625 Dividend 2024: € 138,625 ▲ 70% vs 2023 (€ 81,750) Unchanged	€ 81,971 Dividend 2025: € 81,971 ▼ 41% vs 2024 (€ 138,625) Unchanged	▼ 41%
Bank debt	€ 159,894 Bank debt 2022: € 159,894 First fiscal year in the series	€ 142,824 Bank debt 2023: € 142,824 ▼ 11% vs 2022 (€ 159,894) Favourable step	€ 126,412 Bank debt 2024: € 126,412 ▼ 11% vs 2023 (€ 142,824) Favourable step	€ 110,325 Bank debt 2025: € 110,325 ▼ 13% vs 2024 (€ 126,412) Favourable step	▼ 13%
Balance sheet total	€ 483,445 Balance sheet total 2022: € 483,445 First fiscal year in the series	€ 444,225 Balance sheet total 2023: € 444,225 ▼ 8% vs 2022 (€ 483,445) Unchanged	€ 448,538 Balance sheet total 2024: € 448,538 ▲ 1% vs 2023 (€ 444,225) Unchanged	€ 418,289 Balance sheet total 2025: € 418,289 ▼ 7% vs 2024 (€ 448,538) Unchanged	▼ 7%

Key figures of MEDISKIN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to MEDISKIN?

What happened at MEDISKIN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 17, 2026 New annual accounts for financial year 2025: profit of € 81,971 (▲ 3% vs 2024). Source: NBB ↗
Jun 6, 2016 New establishment in Dilbeek. KBO
Jun 6, 2016 Start of the company according to the CBE. KBO
2016 Lauranne Pierret became a director. NBB

In short

From € 81,750 profit in 2022 to € 81,971 profit in 2025.

Paid € 79,010 in corporate taxes since 2022.

Best year ever: 2025, with € 81,971 profit.

Paid out € 302,345 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at MEDISKIN? We notify you, reason included.

Follow MEDISKIN

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Lauranne Pierret

MEDISKIN

IMMOMED

Behind MEDISKIN is Lauranne Pierret. Lauranne Pierret is also behind IMMOMED.

See the full network in the app

Directors

According to the 2025 annual accounts

Lauranne Pierret

Director

Also active at: IMMOMED

since 2016

Establishments

Establishment units

Physical locations of this company

Registered office

Begijnenborrestraat 26

1700 Dilbeek

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

MEDOC

€ 150,434 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0655.933.992
VAT number: BE 0655.933.992
Registered office: Begijnenborrestraat 26, 1700 Dilbeek
Names & denominations: MEDISKIN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 6 June 2016
Peppol: Active · Active since 19 Nov 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗